GV1001 has been tested in phase I/ II clinical trials in patient with pancreatic cancer, non small cell lung cancer, malignant melanoma and liver cancer, and is currently undergoing clinical trials in pancreatic cancer (Telovac- Phase ...
Korr.: Betalingsstr?mme for milep?le - Pharmexa betaler for milep?le. Pharmexa har betalt f?rste milep?lsbetaling for fors?gene med Telovac, mens anden milep?lsbetaling kr?ver, at selskabet .. - L?s hele nyheden p? Finansnyheder.dk.
GV1001 has been tested in phase I/ II clinical trials in patient with pancreatic cancer, non small cell lung cancer, malignant melanoma and liver cancer, and is currently undergoing clinical trials in pancreatic cancer (Telovac- Phase ...